Elaine Marie Brate

This inventor holds 6 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Abbott Laboratories Corporation, Abbvie Deutschland Gmbh and Co Kg, Abbvie Inc.. Active years: 1998-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elaine Marie Brate. Retrieved from https://idiyas.com/inventor/elaine-marie-brate

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 6 (Patent Applications = 4)

% Patents Active = 66.7

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 5.6

ph-index = 2

Forward Citations = 19(Granted Patents)

Company Filing History:

5 out of 4,190

Abbott Laboratories Corporation

patents

1 out of 167

Abbvie Deutschland Gmbh and Co Kg

where one patent can have more than one assignee

Years Active: 1998-2017

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9636398 - Composition and method for the diagnosis and treatment of iron-related disorders (2017-05-02),

2. 8288111 - Immunoassays exhibiting reduced cross-reactivity with hydrophobic drug analyte metabolites (2012-10-16),

3. 8168165 - Alkylated interleukin-18 compositions (2012-05-01),

4. 7256008 - Determination of concentration of FK778 by competitive immunoassay (2007-08-14),

5. 6797479 - Reagents and methods for the detection and quantification of vancomycin in biological fluids (2004-09-28),

6. 5843634 - Genetically engineered enzymes and their conjugates for diagnostic assays (1998-12-01),

Title: Inventor Spotlight: Elaine Marie Brate

Introduction:

Elaine Marie Brate, a prolific inventor based in Grayslake, IL (US), has made significant contributions to the field of healthcare with her innovative patents and groundbreaking research. With a total of 6 patents to her name, Elaine's work focuses on the diagnosis and treatment of iron-related disorders and immunoassays with reduced cross-reactivity.

Latest Patents:

1. Composition and method for the diagnosis and treatment of iron-related disorders: Elaine's patent introduces antibodies and methods for treating, preventing, and diagnosing iron-related disorders effectively.

2. Immunoassays exhibiting reduced cross-reactivity with hydrophobic drug analyte metabolites: This patent presents immunoassays that show decreased cross-reactivity with analyte metabolites, specifically focusing on hydrophobic drug metabolites, such as cyclosporine A.

Career Highlights:

Elaine has worked with renowned companies such as Abbott Laboratories Corporation and AbbVie Deutschland GmbH & Co. KG, where she has showcased her expertise in developing innovative solutions for complex healthcare challenges. Her patents reflect her commitment to advancing medical diagnostics and treatments.

Collaborations:

Throughout her career, Elaine has collaborated with talented individuals in the field, including coworkers Thomas G. Spring and Shelley R. Holets-McCormack. These collaborations have led to the successful development of revolutionary technologies and methodologies in the healthcare sector.

Conclusion:

Elaine Marie Brate's dedication to innovation and her profound contributions to the healthcare industry through her patents highlight her as a trailblazer in the field. Her relentless pursuit of novel solutions for diagnosing and treating iron-related disorders has improved countless lives and established her as a respected figure in the world of inventors and researchers.

Profile summary based on public USPTO records.